Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial.

نویسندگان

  • Rodney P E Pollard
  • Wayel H Abdulahad
  • Arjan Vissink
  • Nishath Hamza
  • Johannes G M Burgerhof
  • Jiska M Meijer
  • Annie Visser
  • Minke G Huitema
  • Fred K L Spijkervet
  • Cees G M Kallenberg
  • Hendrika Bootsma
  • Frans G M Kroese
چکیده

Citation for published version (APA): Pollard, R. P. E., Abdulahad, W. H., Vissink, A., Hamza, N., Burgerhof, J. G. M., Meijer, J. M., ... Kroese, F. G. M. (2013). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Annals of the Rheumatic Diseases, 72(1), 146-148. DOI: 10.1136/annrheumdis-2012-202071

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

I-36: Simvastatin Effects on Androgens, Inflammatory Mediators, and Endogenous Pituitary Gonadotropins Among Patients with PCOS Undergoing IVF: Results from a Prospective Randomized Placebo-controlled Clinical Trial

Background: To evaluate effects of simvastatin on selected biochemical parameters and reproductive outcome among patients with polycystic ovary syndrome (PCOS) who undergo in vitro fertilization (IVF). Materials and Methods: PCOS patients were randomized to receive either oral simvastatin 20mg/d (n=32) or placebo (n=32) in a prospective, double-blind randomized clinical trial (NCT 005-75601) in...

متن کامل

The effects of rituximab on serum IgE and BAFF

BACKGROUND There are few treatment options for patients with severe atopic asthma. Antagonism of IgE is an effective strategy. We investigated, by utilizing serum samples from a clinical trial of Rituximab in patients with Idiopathic Thrombocytopenic Purpura, if B cell depletion would decrease serum IgE and therefore be a potential therapeutic option. FINDINGS In a placebo-controlled randomiz...

متن کامل

Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance

INTRODUCTION B cell-activating factor of the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) play a crucial role in B cell development, survival, and antibody production. Here we analyzed the serum levels of BAFF and APRIL and their respective clinical associations in patients with an immunoglobulin (Ig) G4-related disease (IgG4-RD). METHODS We measured serum l...

متن کامل

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome

Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We have previously suggested clinical benefit from B-cell depletion using the monoclonal anti-CD20 antibody rituximab in a randomized and placebo-controlled study. Prolonged responses were then demonstrated in an open-label phase-II study with maintenance rituximab treatment. Using blood samples from pati...

متن کامل

Investigation of serum APRIL and BAFF levels in pemphigus vulgaris patients in Southern Iran

Background: Pemphigus vulgaris, the most common form of pemphigus, is due to the production of auto-antibodies directed against adhesion molecules (desmoglein 1 and 3) that belong to the cadherin family. B cell-activating factor of the TNF family (BAFF) and a proliferation-inducing ligand (APRIL) may play a significant role in autoimmune diseases such as pemphigus vulgaris. Only a few studies h...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Annals of the rheumatic diseases

دوره 72 1  شماره 

صفحات  -

تاریخ انتشار 2013